Navigation Links
Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
Date:9/18/2007

ANN ARBOR, Mich., Sept. 18 /PRNewswire-FirstCall/ -- In a study published by the Journal of Supportive Care in Cancer, researchers from Thomson Healthcare found that when cancer patients used a handheld computer before office visits to rate and report their pain, fatigue, and depression, doctors were significantly more likely to address these potentially debilitating symptoms and side effects. Thomson Healthcare is part of The Thomson Corporation (NYSE: TOC; TSX: TOC).

The three-year study, sponsored by the Robert Wood Johnson Foundation, evaluated the PACE System(TM) (Patient Assessment, Care and Education), which uses notebook-sized tablet PCs equipped with touch-screen technology and specialized software. When patients arrived for office visits, they used the handheld computers to complete a self-assessment that automatically uploaded to a wireless network and produced a detailed, real-time report on their symptoms for their doctors.

Researchers assessed whether this technology effectively addressed a chronic problem in cancer treatment: chemotherapy side effects often are not reported, diagnosed, or treated because patients lack information about the success of interventions and physicians lack detailed, real-time information on patients' symptoms.

"Many times, chemotherapy-related symptoms and side effects can be prevented or controlled, but they often go untreated because patients don't bring them up and it's challenging for a busy oncology practice to incorporate symptom screening into its daily workflow," said Tami Mark, Ph.D., associate research director at Thomson Healthcare and lead investigator for the study. "This study found that the right technology can effectively address the problem w
'/>"/>

SOURCE Thomson Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
2. Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
3. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
4. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
5. NovaDel Announces Positive Data from Two Studies Comparing Zolpidem Oral Spray to Ambien Tablets
6. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
7. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
8. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
9. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, MammographyEquipment-AGlo...ker.com/p0164330/Mammography-Equipment---A-Global-...eastcancerinindustrializedaswellasdevelopingnation...hymarket.Globally,escalatingawarenessaboutbreastca...
(Date:11/25/2009)...,, EASTBRUNSWICK,N.J.,Nov.25/PRNewswire/--Sw...ctdigitalRadiography( ddR )systems,announcedtodayt...estorwithalongtermviewtowardsgrowingSwissray,smedi...intellectualproperty,aswellascontractsandinventory...tomovetothenextleveloftechnologicaladvancementswit...
(Date:11/25/2009)...,, SANDIEGO,Nov.25/PRNewswire-FirstCall/--Nu...cusedondevelopingproductsforminimallydisruptivesur...lhostaconferencecallonMonday,November30,2009,at5:3...rentissuesrelativetoreimbursementfortheCompany,spr...byashortquestionandanswersession.Thedial-innumbers...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Swissray International Announces New Ownership 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Board Certified Cardiologist Dr Stephen Sinatra Featured on Searchvitaminsupplements com 51077 1Board Certified Cardiologist Dr Stephen Sinatra Featured on Searchvitaminsupplements com 51077 2Photos 3A 248 Million in Asthma Research Grants Awarded to 12 Scientists 51072 1Photos 3A 248 Million in Asthma Research Grants Awarded to 12 Scientists 51072 2FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen 28R 29 28decitabine for injection 29 to Treat Patients with Myelodysplastic Syndromes 28 4701 1FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen 28R 29 28decitabine for injection 29 to Treat Patients with Myelodysplastic Syndromes 28 4701 2
... technology has enabled more and more laboratory t...e, the central laboratory is hardly threatened wit...dium and large labs are busier than ever before, a...dard reliability and ability to handle very large ...al position in the clinical landscape. , ,This...
...Ph.D. Harvard Medical School ,Contributing Edito...0 deaths per year, breast cancer undoubtedly quali...ms. Recently, efforts to develop early detection ...tant progress. This is particularly true at the m...ssion have translated into new diagnostic tests an...
Other Medicine Technology:Immunoassay Systems - Your Laboratory Workhorse 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3
(Date:11/27/2009)... Walking and cycling plus low-emission vehicles m..., , FRIDAY, Nov. 27 (HealthDay News) -- E...ad of using cars would offer much greater public h... vehicles, U.K. researchers have found. , The s... of alternative urban land transport scenarios for...
(Date:11/27/2009)... , Specialist manufacture...r products are saving millions of dollars by bring...ign process. Increasing numbers of pro-active medi... experts at the concept stage of their projects, e...xisting design processes or potentially outdated t...
(Date:11/26/2009)... , The copper sequestering drug tetrathiomolybdat...n the treatment of Wilson disease, a disease cause... cancers. That much is known. Very little, however...ar level. , A new study led by Northwestern Univ...clue: the three-dimensional structure of TM bound ...
(Date:11/26/2009)... , Research Triangle Dent...central North Carolina, today announced the expans...ified LUMINEER Dentist, Dr. Doug Macmillan. , ...arch Triangle Dental is pleased to announce that D...ist, recently completed an additional advanced tra...
(Date:11/25/2009)... ,, EMERYVILLE,Calif.,Nov.25/PRNewswire-Firs...odayannouncedthatthecompanywillhosttwoinvestoreven...er7,2009-9:00a.m.CT/10:00a.m.ET ,, Principali...gcarfilzomibinrelapsedand/orrefractorymultiplemyel...(ASH)AnnualMeetingandExpositioninNewOrleans,LA.The...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...pharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiop...hat production of its flagship drug, Cisatracurium...of 2009 compared to production in the first quarte...e first quarter of 2009, compared to 47,700 units ...
...es ,live, , , WASHINGTON, May 14 Starting Monday... connected by voice, video and data lines to speci...ferral center 130 miles away. A year after announc...t critical care to their patients, the first hospi...
...u best for this high-risk group, agency says , ...ealth officials said they,re seeing some complicat...es to spread across the country, and that this hig...t,s the seasonal influenza or pandemics of the pas...
...therapy led to better post-discharge function, stu...ews) -- Interrupting the sedation of critically il...age them in brief physical therapy may lead to bet...ase are often complications of the immobilization ...
...o the Stem for Life Foundation , , NEW YORK, May ...oneering the pre-disease collection, processing an... medical need, announced today it has signed an ag... supplement - AIO Premium Cellular Health. , , ...
...d Their Own as Downturn Took Hold , , WASHINGTON,...rofit hospitals and health care systems in the U.S...isers in charge of major gifts and planned giving ...her important findings come from the latest series...
Other Medicine News:Health News:Sinobiopharma Announces 350% Increase in Production of Its Flagship Drug in the First Quarter of 2009 Over the Same Period in 2008 2Health News:Maryland ICU Patients Connected to Remote Critical Care Staff, Improving Quality and Safety 2Health News:Maryland ICU Patients Connected to Remote Critical Care Staff, Improving Quality and Safety 3Health News:CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu 2Health News:CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu 3Health News:CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu 4Health News:CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu 5Health News:CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu 6Health News:CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu 7Health News:CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu 8Health News:CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu 9Health News:Early Exercise Boosts Outcomes for ICU Patients 2Health News:NeoStem Signs Agreement for Ceres Living, Inc. to Market Innovative Nutritional Supplement Designed to Optimize Stem Cell Functions 2Health News:NeoStem Signs Agreement for Ceres Living, Inc. to Market Innovative Nutritional Supplement Designed to Optimize Stem Cell Functions 3Health News:Hire More Fundraising Rain-Makers During Recession, New AHP Study Concludes 2
PelviSoft® Acellular Collagen BioMesh
High Pure Viral RNA Kit
...s a simple, fast and cost-effective method to puri...s system utilizes guanidine thiocyanate and 2-merc...Nase and denature proteins. Purified viral RNA is ... and RNase protection assays. This system is ideal...
MicroReader 4 Plus
Medicine Products: